NCT02756273

Brief Summary

During the creation of an ileostomy, a bridge device is systematically placed in an aim to reduce wound and peritoneal contamination by stools. Nevertheless no evidence was reported to justify this issue. Moreover the placement of a bridge device increases the difficulty of nurse cares and is associated with its own morbidity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 29, 2016

Completed
11 days until next milestone

Study Start

First participant enrolled

May 10, 2016

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2023

Completed
Last Updated

September 6, 2023

Status Verified

September 1, 2023

Enrollment Period

6 years

First QC Date

April 27, 2016

Last Update Submit

September 5, 2023

Conditions

Keywords

ileostomymorbiditycolorectal surgery

Outcome Measures

Primary Outcomes (1)

  • absence of postoperative morbidity

    the primary outcome is a composite score. The complication is considered as present if the patient experienced at least one of the following events: surgical site infection (either superficial, deep or distant); a parastomal irritation; a stomal necrosis; parastomal hernia; a stoma stenosis; a stoma prolapsus or a stoma leakage. The primary endpoint is evaluated by a nurse devoted to stoma care according to an open label.

    two months after the surgery

Secondary Outcomes (7)

  • difficulty of the stoma conception

    at the end of the surgery

  • the reoperation rate

    postoperative month one

  • the mortality rate

    postoperative month one

  • the postoperative morbidity

    postoperative month one

  • the specific quality of life

    postoperative year one

  • +2 more secondary outcomes

Study Arms (2)

no bridge device

EXPERIMENTAL

After the ileostomy creation, no bridge device was placed.

Device: no bridge device

bridge device

ACTIVE COMPARATOR

A bridge device was placed after the stoma creation.

Device: bridge device

Interventions

bridge device
no bridge device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • colorectal disease (cancer; diverticulitis; Crohn disease; inflammatory bowel disease)
  • requiring elective surgery with an ileostomy
  • patient having given his consent before the enrollment

You may not qualify if:

  • patient with early closure of the stoma (within 10 days after the colorectal surgery)
  • long term corticoids
  • emergency surgery
  • history of stoma in the side of the stoma placement planned for the study
  • BMI \>50
  • No signature of the consent to participate in the study
  • Physical or mental state not allowing participation in the study
  • Contraindication to surgery
  • ASA classification (American Society of Anesthesiologists) IV-V or life expectancy \<48h
  • Pregnancy or breastfeeding
  • Patient under guardianship or guardianship or patient deprived of liberty by a judicial or administrative decision (in accordance with articles L1121-6 and L1121-8 of the Public Health Code)
  • Minor patient
  • Patient without social protection
  • no anastomosis
  • no ileostomy
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Amiens Universitary Hospital

Amiens, France

Location

Beauvais hospital

Beauvais, France

Location

Chu Rouen

Rouen, 76000, France

Location

Related Publications (6)

  • Matthiessen P, Hallbook O, Rutegard J, Simert G, Sjodahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007 Aug;246(2):207-14. doi: 10.1097/SLA.0b013e3180603024.

    PMID: 17667498BACKGROUND
  • Sagap I, Remzi FH, Hammel JP, Fazio VW. Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA)--a multivariate analysis. Surgery. 2006 Oct;140(4):691-703; discussion 703-4. doi: 10.1016/j.surg.2006.07.015.

    PMID: 17011918BACKGROUND
  • Panis Y, Maggiori L, Caranhac G, Bretagnol F, Vicaut E. Mortality after colorectal cancer surgery: a French survey of more than 84,000 patients. Ann Surg. 2011 Nov;254(5):738-43; discussion 743-4. doi: 10.1097/SLA.0b013e31823604ac.

    PMID: 21997816BACKGROUND
  • Oberkofler CE, Rickenbacher A, Raptis DA, Lehmann K, Villiger P, Buchli C, Grieder F, Gelpke H, Decurtins M, Tempia-Caliera AA, Demartines N, Hahnloser D, Clavien PA, Breitenstein S. A multicenter randomized clinical trial of primary anastomosis or Hartmann's procedure for perforated left colonic diverticulitis with purulent or fecal peritonitis. Ann Surg. 2012 Nov;256(5):819-26; discussion 826-7. doi: 10.1097/SLA.0b013e31827324ba.

    PMID: 23095627BACKGROUND
  • Cottam J, Richards K, Hasted A, Blackman A. Results of a nationwide prospective audit of stoma complications within 3 weeks of surgery. Colorectal Dis. 2007 Nov;9(9):834-8. doi: 10.1111/j.1463-1318.2007.01213.x. Epub 2007 Aug 2.

    PMID: 17672873BACKGROUND
  • Sabbagh C, Mauvais F, Demouron M, Browet F, Tartar L, Hariz H, Bridoux V, Tuech JJ, Diouf M, Regimbeau JM. Is a bridge (rod) necessary for loop ileostomy? A phase II randomized control trial. Tech Coloproctol. 2025 Mar 25;29(1):87. doi: 10.1007/s10151-025-03132-4.

Study Officials

  • Charles SABBAGH

    CHU Amiens Picardie

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2016

First Posted

April 29, 2016

Study Start

May 10, 2016

Primary Completion

May 1, 2022

Study Completion

October 2, 2023

Last Updated

September 6, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations